-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

506.P1.31 506. Bone Marrow Microenvironment: Poster I

Symposia: Bone Marrow Microenvironment Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acquired Marrow Failure Syndromes, Lymphoid Leukemias, ALL, Acute Myeloid Malignancies, AML, MDS, Bone Marrow Failure Syndromes, MPN, Plasma Cell Disorders, Chronic Myeloid Malignancies, Diseases, Lymphoid Malignancies, Myeloid Malignancies
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Wataru Kitamura1*, Masakazu Shinohara, MD PhD2*, Akifumi Matsumura, MD1*, Takashi Moriyama, MD1*, Masaya Abe, MD1*, Yayoi Ueda, MD1*, Shinichi Ishii, MD PhD3*, Tomohide Suzuki, MD PhD3*, Mitsuaki Ono, DDS PhD4*, Yoshinobu Maeda, MD, PhD1 and Noboru Asada, MD, PhD5

1Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2The Integrated Center for Mass Spectrometry, Kobe University Graduate School of Medicine, Kobe, JPN
3Division of Hematology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
4Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
5Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan

Driti Ashok1,2*, Dennis Raith3,4*, Martin Helmstädter, PhD5,6*, Geoffroy Andrieux, PhD7*, Séverine Kayser5,6*, Sangya Chatterjee1*, Judith Treiber1*, Khalid Shoumariyeh, MD1*, Tim Struessmann, MD1*, Valentin Wenger1*, Julian Rapp, MD1*, Jesus Duque Afonso, MD1, Michael Lübbert, MD1, Robert Zeiser, MD1, Melanie Boerries, MD, PhD7,8*, Justus Duyster, MD1* and Tanja Nicole Hartmann, PhD1

1Department of Medicine I, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2University of Freiburg, Faculty of Biology, Freiburg, Germany
3LABMaiTE GmbH, Freiburg, Germany
4Department of Computer Science, University of Freiburg, Freiburg, Germany
5Renal Division, Department of Medicine, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany
6EMcore, Renal Division, Department of Medicine, University Hospital Freiburg, University Faculty of Medicine, Freiburg, Germany
7Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
8German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center - University of Freiburg, Freiburg, Germany

Mauricio Nicolás Ferrao Blanco, PhD, Bexultan Kazybay*, Olaf Heidenreich* and Josef Vormoor, MD PhD*

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Konur Oyman, MSc1*, Wantong Li2, Annika Chura2*, Sharyn D. Baker, PharmD3 and Bradley Wayne Blaser, MD, PhD1

1Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3Ohio State University, Columbus, OH

Hideaki Mizuno, MD, PhD1*, Yuki Nishida, MD, PhD1, Edward Ayoub, PhD1*, Akshay Basi2*, Andrea Bedoy1*, Javier A. Gomez2*, Jared K. Burks, PhD2*, Rashmi Kanagal-Shamanna, MD3 and Michael Andreeff, MD, PhD1

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Christina M Kaszuba, MS1,2, Cameron D Baker3*, Benjamin J Rodems, MS2,4*, Sonali Sharma, PhD2, Jane L. Liesveld, MD2,5, Laura M. Calvi, M.D.2,6, Michael W. Becker, MD2,7, Craig T Jordan, PhD8, John M. Ashton, PhD, MBA2* and Jeevisha Bajaj, Ph.D.2,4

1Department of Biomedical Engineering, University of Rochester, Dansville, NY
2Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
3Genomics Research Center, University of Rochester Medical Center, Rochester, NY
4Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY
5Division of Hematology and Oncology, University of Rochester Medical Center, Rochester, NY
6Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, NY
7University of Rochester Medical Center, Rochester, NY
8Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO

Qiongdi Zhang, PhD1*, Joshua Theriot, MS1*, Donghong Cai, PhD2*, Jian Xu, PhD2 and Sisi Zheng, MD3,4

1Division of Hematology-Oncology, Department of Pediatrics, University of Texas Southwestern, Dallas, TX
2Center of Excellence for Leukemia Studies (CELS), Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
3Children's Health, University of Texas Southwestern, Dallas, TX
4Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Texas Southwestern, Dallas, TX

Monika Kutyna, PhD1,2,3*, Daniel Thomas, MBBS, PhD1,2,3* and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA1,2,3

1Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia
2Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
3South Australian Health and Medical Research Institute, Adelaide, SA, Australia

Aijie Huang, MD1*, Guangyu Sun1*, Bingbing Yan1*, Baolin Tang1*, Kaidi Song1*, Yaxin Cheng1*, Meijuan Tu2*, Tianzhong Pan2*, Yue Wu1*, Dongyao Wang, PhD1* and Xiaoyu Zhu1

1Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
2Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China

Ruochen Dong, Ph.D.1, Hua Li, Ph.D.1*, Xi He, MD,. Ph.D.1*, Chen Wang2*, Anoja Perera1*, Seth Malloy1*, Jonathon Russell1*, Wenting Li1*, Kaitlyn Petentler1*, Xinjian Mao, PhD1, Zhe Yang, PhD1, Michael Epp1*, Kate Hall1*, Allison Scott1*, Mary C McKinney1*, Shengping Huang, Ph.D1*, Sarah Smith1*, Mark Hembree1*, Yongfu Wang1*, Zulin Yu3*, Jeff Haug1*, Jay Unruh, Ph.D.1*, Brian Slaughter1*, Xunlei Kang, PhD2* and Linheng Li, Ph.D.1

1Stowers Institute for Medical Research, Kansas City, MO
2University of Missouri School of Medicine, Columbia, MO
3Stowers Institute for Medical Research - Kansas City, MO, Kansas City, MO

*signifies non-member of ASH